Skip to content

Efficacy of circumferential intensive phototherapy in treating neonatal hyperbilirubinemia

Efficacy of circumferential intensive phototherapy in treating neonatal hyperbilirubinemia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032551
Enrollment
Unknown
Registered
2020-05-02
Start date
2020-05-12
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal hyperbilirubinemia

Interventions

control group:ordinary phototherapy
experimental group:circumferential intensive phototherapy

Sponsors

Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Infants with hyperbilirubinemia; 2. Babies whose mothers prescribe milk timely; 3. Infants with <=37 weeks gestational age < 42 weeks; 4. Infants with 2500 g <= birth weight <= 4000 g; 5. Infants with normal clinical physical examination.

Exclusion criteria

Exclusion criteria: 1. Infants whose mothers have abnormal obstetric history before delivery (such as pregnancy induced hypertension, premature rupture of amnion, massive hemorrhage, etc.); 2. Infants whose mothers used oxytocin before delivery; 3. infants with intrauterine distress or history of postnatal asphyxia; 4. Infants with meconium discharge delay; 5. Infants with polycythemia, maternal fetal blood group incompatibility hemolysis, infection, scalp hematoma, intracranial or gastrointestinal hemorrhage and other diseases; 6. The object of congenital malformation; 7. Objects lacking G6PD; 8. Objects with other diseases.

Design outcomes

Primary

MeasureTime frame
percutaneous bilirubin;Adverse events;

Countries

China

Contacts

Public ContactFei Yang

Hangzhou Obstetrics and Gynecology Hospital

yangfei19870826@126.com+86 13732261447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026